Jing W. Email & Phone Number
Who is Jing W.? Overview
A concise factual answer block for searchers comparing this professional profile.
Jing W. is listed as VP, program leader for Sabirnetug at Acumen Pharmaceuticals, Inc., based in Greater Boston, United States, United States. AeroLeads shows a matched LinkedIn profile for Jing W..
Jing W. previously worked as Founding CEO, COO, President, Board Director at Vigeo Therapeutics and Director Board Of Directors at Enzymetrics Bioscience, Inc.. Jing W. holds Post-Doctoral Fellowship from Harvard Medical School.
Email format at Acumen Pharmaceuticals, Inc.
This section adds company-level context without repeating Jing W.'s masked contact details.
Review company-level records connected to Jing W. before choosing the right outreach path.
About Jing W.
An experienced biotech executive with demonstrated versatile and deep expertise in building companies, developing preclinical and clinical stage molecules, raising funding, and negotiating strategic collaborations. A decisive leader with experience in company formation, team and infrastructure building, leading teams with diverse expertise, and operating in a capital efficient manner. Broad experience in business development, strategy & operations, program management, and R&D in biotech and pharmaceutical industries.
Listed skills include Leadership, Research And Development, Clinical Trials, Translational Medicine, and 37 others.
Jing W.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Jing W. work experience
A career timeline built from the work history available for this profile.
Founding Ceo, Coo, President, Board Director
Current- Cofounded the company in 2015- Oversees fundraising, research and clinical development, business development, and pipeline & program management. - Led the development of lead asset VT1021 from preclinical discovery to registration stage clinical trial in solid tumor indications
Director Board Of Directors
Independent Board DirectorAdvise in fundraising, early-stage company buildup, business development strategy and R&D strategy
Board Advisor
Advise in fundraising, early-stage company buildup, business development strategy and R&D strategy
Global Program Lead, Zenula (Fda Approved) (Tesaro)
Program Leader & Dir Of Portfolio Management
- led global programs teams to develop therapies for ultra-rare orphan diseases: ALXN1101 for MoCD (Nulibry; FDA approved); ALXN1102/1103 for PNH and other indications- led portfolio management and strategic planning functions for Translational Medicine group (Research and Early Development)
Global Program & Portfolio Lead, Oncology Bu
Led multiple global programs from pre-IND to clinical PoC including Tabrecta™ (capmatinib; FDA approved)- Provide strategic and operational leadership- Oversee program budget and strategic directions- Lead cross-functional task forces/sub-teams to establish and ensure alignment across all line functions
Strategy & Operations, Strategic Alliances
Led evaluation of in-licensing opportunities for Regenerative Medicine, new indications, and ophthalmology disease area;Led strategic analysis of specific strategy initiatives;Led operational analysis of Novartis deal process
Head Of Business Development, Novartis Drug Discovery Incubator
Led all aspects of business development and alliance management activities for the groupProject team head: led two projects in neuromuscular disorders and oncology indications
Director, Strategic Initiatives
Established Pediatric Formulation Initiative, which focused on developing pediatric specific clinical development projects;Licensed technologies and raised initial funding for the Initiative;Established partnership with various CROs and collaborators via creative deal structures
Venture Analyst
Led evaluation of investment opportunities;Responsible for drafting business plan and fund-raising presentations for incubated start-up company
Research Fellow, Juvenile Diabetes Foundation International (Jdfi)
Winner of Best Basic Research Project presented at Endocrine Society annual meeting, 2000
Research Fellow, Howard Hughes Medical Institute (Hhmi)
Jing W. education
Post-Doctoral Fellowship
Phd, Pharmacology & Therapeutics
Mba, Management Strategy, Finance & Marketing
Education record
Bachelor Of Science (B.Sc.), Pharmacology
Education record
Frequently asked questions about Jing W.
Quick answers generated from the profile data available on this page.
What company does Jing W. work for?
Jing W. works for Acumen Pharmaceuticals, Inc..
What is Jing W.'s role at Acumen Pharmaceuticals, Inc.?
Jing W. is listed as VP, program leader for Sabirnetug at Acumen Pharmaceuticals, Inc..
Where is Jing W. based?
Jing W. is based in Greater Boston, United States, United States while working with Acumen Pharmaceuticals, Inc..
What companies has Jing W. worked for?
Jing W. has worked for Acumen Pharmaceuticals, Inc., Vigeo Therapeutics, Enzymetrics Bioscience, Inc., Deepmed Incorporated China 深药科技(苏州)有限公司, and Gsk.
How can I contact Jing W.?
You can use AeroLeads to view verified contact signals for Jing W. at Acumen Pharmaceuticals, Inc., including work email, phone, and LinkedIn data when available.
What schools did Jing W. attend?
Jing W. holds Post-Doctoral Fellowship from Harvard Medical School.
What skills is Jing W. known for?
Jing W. is listed with skills including Leadership, Research And Development, Clinical Trials, Translational Medicine, Cro, Infectious Diseases, Start Ups, and Clinical Research.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial